| [1] |
Gu Dandan, Zhou Xiaoxian, Wang Jingxian, Wu Chunxiao.
Rectal cap polyposis: A case report and literature review
[J]. Clinical Focus, 2024, 39(9): 828-832.
|
| [2] |
Zhao Jinxia, Kang Huihui, Zhang Yao, Fu Shengjun, Sun Pengfei.
Correlation between serum lipids before radical gastrectomy for gastric cancer and the prognosis
[J]. Clinical Focus, 2024, 39(10): 889-895.
|
| [3] |
Liu Jing, Liu Lianpei, Zhang Mengmeng, Chai Linlin, Li Rong, Zhu Liying.
Gastric adenocarcinoma of fundic gland type: A case report and literature review
[J]. Clinical Focus, 2024, 39(10): 929-934.
|
| [4] |
Zhao Xuhui, Huang Xiaomin, Da Dezhuan, Xu Yan, Cui Xiaodong, Li Hongling.
Screening of glycolysis-related genes for predicting the prognosis of patients with gastric cancer: Based on bioinformatics
[J]. Clinical Focus, 2024, 39(1): 20-29.
|
| [5] |
Lyu Chang, Zhou Liming.
Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis
[J]. Clinical Focus, 2023, 38(9): 779-787.
|
| [6] |
Wang Yingnan, Zhao Qi, Bai Haiwei, Wu Danna, Wei Jinmei, Li Shengjiang, Li Ruiling, Zhang Ruixing.
Clinical characteristics and risk factors of gastric cancer-related stroke
[J]. Clinical Focus, 2023, 38(5): 417-422.
|
| [7] |
Wang Junhong, Gao Zhenhua, Zhang Ronglong, Ji Haomin, Zhao Xinke, Da Mingxu.
Quality analysis of the literatures associated with gastric cancer diagnosis from 1980-2021——A bibliometric analysis based on the Web of Science database
[J]. Clinical Focus, 2023, 38(12): 1117-1124.
|
| [8] |
Feng Xiongcai, Huo Lijuan.
Furazolidone-containing quadruple therapy for Helicobacter pylori:A case report of severe adverse reactions
[J]. Clinical Focus, 2022, 37(6): 548-550.
|
| [9] |
Tao Jianan, Tian Wangzhao, An Qi, Wang Xuehong, Zhang Shengqi, Liu Ji.
Expression and clinical significance of SLP-2 in gastric cancer: A meta-analysis
[J]. Clinical Focus, 2022, 37(4): 299-304.
|
| [10] |
Huang Yehong, Liu Gaifang, Xin Chenxi, Zhao Yunhong, Wu Jing.
Searching for an optimal therapy for H.pylori eradication: High-dose proton-pump inhibitor dual therapy vs. bismuth-containing quadruple therapy
[J]. Clinical Focus, 2022, 37(3): 230-233.
|
| [11] |
Yu Jinghong, Zhao Yan, Yu Shufeng, Wang Caixia.
Investigation and analysis on helicobacter pylori infection of children in Qingdao region
[J]. Clinical Focus, 2022, 37(2): 141-144.
|
| [12] |
Li Shufan, Wang Yuxiu, Jiang Zhenghua.
The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation
[J]. Clinical Focus, 2022, 37(11): 985-991.
|
| [13] |
Zhang Yiming, Li Mingzhao, Gu Xin.
Clinicopathological analysis of colorectal mixed adeno-neuroendocrine carcinoma: 8 cases report
[J]. Clinical Focus, 2022, 37(10): 921-926.
|
| [14] |
He Yiwen, Qiao Tiankui.
Clinical value of CEA, CA125, and CYFRA21-1 levels in efficacy evaluation of EGFR-TKIs in the treatment of EGFR mutation-positive non-small cell lung adenocarcinoma
[J]. Clinical Focus, 2021, 36(3): 220-224.
|
| [15] |
Jin Ying, Wang Pai, Feng Shibing.
Application value of Helicobacter pylori, PG and G17 in diagnosing precancerous lesions of gastric cancer
[J]. Clinical Focus, 2021, 36(3): 233-237.
|
